NCT06103045Completed
The Effects of Unilateral and Bilateral Mirror Therapy on Upper Extremity Function in Early Subacute Stroke.
The Effects of Unilateral and Bilateral Mirror Therapy on Upper Extremity Function in Early Subacute Stroke: A Pilot Randomized Controlled Trial.
Source: ClinicalTrials.gov · Last updated 20 May 2026
Brief summary (registry, in English)
Objective: To comparing the effects of unilateral and bilateral mirror therapy on upper extremity function of stroke at early subacute stage. We hypothesize there are different effects between unilateral and bilateral mirror therapy on stroke patients at early subacute stage. Method: Patients with unilateral stroke and the onset within one month will be recruited and then randomly allocated to one of the three groups (including unilateral mirror therapy, bilateral mirror therapy, and conventional occupational therapy). Patient will receive 20 consecutive sessions of intervention (5 time per week, totally 4 weeks) and assessments before and after the intervention within one week. In each intervention session, patients will receive 30 minutes unilateral or bilateral mirror therapy depending on their allocated groups and then 30 conventional occupational therapy. The patients recruited in the conventional occupational therapy group will receive 60 minute conventional therapy. The outcome measures at pre- and post-treatment will including the Fugl-Meyer Assessment for upper extremity (FMA-UE), the Modified Ashworth Scale (MAS), the Jamar Hydraulic Hand Dynamometer, the Chedoke Arm and Hand Activity Inventory (CAHAI), and the Revised Nottingham Sensory Assessment (rNSA).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 49 (actual)
- First submitted
- 22 Oct 2023
- Start date
- Feb 2023
- Primary completion date
- Jul 2025
- Lead sponsor
- National Taiwan University Hospital Hsin-Chu Branch
- Diseases
- Stroke
- NCT number
- NCT06103045
What you commit to
- Study type: Interventional
- Participants enrolled: 49
- From Feb 2023 to the primary completion date, Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving botulinum toxin injection within 3 months
Other illness
- Unstable vital sign or complicating with other symptoms of neurological disease
- Auditory or visual function impairment
- Complicating with perceptual impairment (e.g., apraxia, neglect, or visual agnosia)
Other
- Complicating with Wernicke's or Broca's aphasia
Who the study is looking for
- Unilateral stroke onset within 1 month
- The score of Mini-Mental State Examination (MMSE) is more than 24
- The score of Fugl-Meyer Assessment for upper extremity (FMA-UE) is between 18 to 56
- The score of Modified Ashworth Scale (MAS) is less than 3
- Willing to receive 3-5 sessions of the intervention per week, total 20 sessions consecutively
- Willing to sign informed consent
Age in the registry: 20 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan University Hospital Hsin Chu Branch Coordinator of this site? Confirm its status | Hsinchu | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.